U09.9
Conditions
Interventions
Group 1: Vocal-based respiratory therapy with short-phrase/strengthening vocal elements, (e.g. diaphragm thrusts on consonants), 1 therapy session over 6 weeks
Group 2: Vocal-based respiratory therapy
Sponsors
Universitätsmedizin Greifswald/ Unfallkrankenhaus Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age >= 18 years - History of COVID-19 disease (PCR-confirmed) at least 4-6 weeks prior to study inclusion - COVID-19 associated respiratory dysfunction (shortness of breath, dyspnoea, respiratory rate increase) - Sufficient knowledge of German as mother tongue or foreign language level at least CI - Written consent for study participation - indication for outpatient or inpatient therapy
Exclusion criteria
Exclusion criteria: - Acute COVID-19 disease - Patients with marked pulmonary fibrosis or other structural lung changes with functional impact after COVID-19 disease. - Chronic pulmonary disease prior to COVID-19 (asthma, CORD etc.) - Pre-existing or COVID-19 neurological disease with impact on respiratory function - Patients ventilated in the acute situation with abnormal laryngoscopic findings - Acute laryngitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory parameters (Bodyplethymography) at rest and after exercise using a 6-minute walk test and phonation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Parameters of cardiological function diagnostics (heart rate and heart rate variability, RR, echocardiography), change in subjective dyspnoea, voice function (Acoustic Voice Quality Index), tone holding time (MPT), Dysphonia Severity Index DSI), mental health, quality of life. | — |
Countries
Germany
Contacts
Public ContactAnke Steinmetz
Physikalische und Rehabilitative Medizin
Outcome results
None listed